wellrank.ai
Sign In

My compounded semaglutide provider shut down. Where should I move my treatment?

ClaudeswitchingCollected Jul 24, 2026, 09:42 UTC

Verbatim response from Claude

Moving Your Compounded Semaglutide Treatment

This is a common situation right now due to FDA enforcement actions. Here are your main options:

Branded GLP-1 Medications (Most Straightforward)

  • Ozempic/Wegovy (Novo Nordisk) - The original semaglutide; Wegovy is FDA-approved specifically for weight loss
  • Zepbound/Mounjaro (Eli Lilly) - Tirzepatide, often considered comparable or superior for weight loss
  • Ask your doctor or use manufacturer savings programs to reduce cost

Telehealth Platforms with Licensed Prescribers

  • Hims & Hers - Now offers branded tirzepatide programs
  • Ro - Connects you with prescribers for branded options
  • Found - Medication + behavioral coaching
  • Calibrate - Comprehensive metabolic health program

Cost-Saving Options

  • Mark Cuban's Cost Plus Drugs - Check for available GLP-1 options
  • GoodRx - Compare pharmacy pricing
  • Manufacturer coupons - Novo Nordisk and Lilly both offer assistance programs

Important Notes

  • ⚠️ Verify any new provider is working with FDA-approved medications
  • Some telehealth companies still offer 503B pharmacy compounded versions where legally permitted
  • Bring your dosing history to help new prescribers match your current regimen

Would you like more detail on any of these options?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.